EFA is the European voice for over 200 million people living with allergies and airway diseases. We bring together national associations from 25 countries and channel their knowledge and demands to European institutions.

In 2019, we launched #ShowLeadership, a pan European communications campaign to highlight the results of EFA’s asthma and COPD survey “Active Patients Access Care”, and a roadmap to encourage targeted action on allergy and airways diseases at European level. 

#Showleadership underpins EFA’s advocacy work. We connect stakeholders to ignite change and bridge the gaps between a wide range of policy issues to support more effective and comprehensive strategies – strategies that address the needs of our community. We strive to achieve greater patient participation in decision-making at local, national and European levels.

We thank our Sustainable Corporate Funders Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Sanofi Genzyme and Regeneron for their support to our #ShowLeadership initiative with unrestricted grants.